STOCK TITAN

Cypherpunk Technologies Inc. Form 4 Filings

CYPH NASDAQ

Every Form 4 that Cypherpunk Technologies Inc. (CYPH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CYPH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYPH filings page.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. director Oei Khing Djien sold 168,750 shares of Common Stock on September 25, 2026, at $3.92 per share. The sale covered estimated taxes connected with the settlement of restricted stock units; his reported direct holdings afterward were 0 shares. No Rule 10b5-1 plan was reported.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. director Patricia A. Martin sold 50,000 shares of common stock on September 23, 2026, at $3.86 per share. The shares were sold to cover estimated taxes to be paid in connection with the settlement of restricted stock units. She directly held 118,750 shares after the transaction.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. (CYPH) director Thomas John Dietz reported selling 20,000 shares of common stock on 2026-08-26 at a reported price of $1.72 per share in a sale classified as an open market or private transaction. After this transaction, he directly holds 132,500 common shares.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. (symbol: CYPH) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported insider transactions indirectly involving Winklevoss Treasury Investments, LLC ("WTI"), an entity managed by reporting person William Patrick McEvoy III. On August 17, 2026, WTI exercised 16,570,852 Pre-Funded Warrants at an exercise price of $0.001 per share, acquiring the same number of CYPH common shares and bringing WTI’s indirect common stock holdings to 24,854,613 shares. On the same date, under an Asset Purchase Agreement, WTI received additional Pre-Funded Warrants to purchase 43,290,042 CYPH common shares as consideration for the sale of certain assets and rights, at a stated price of $0.77 per warrant. The Pre-Funded Warrants are exercisable immediately, have no expiration date, and include a 19.99% beneficial ownership limitation that prevents exercises that would cause WTI and related parties to own more than 19.99% of CYPH’s outstanding common stock after exercise. McEvoy disclaims beneficial ownership of WTI’s securities except to the extent of any pecuniary interest.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported insider-related entity activity involving pre-funded warrants and common stock held through Winklevoss-associated entities. Winklevoss Treasury Investments, LLC (WTI), a subsidiary of Winklevoss Capital Fund, LLC, received Pre-Funded Warrants to purchase 43,290,042 shares of common stock under an Asset Purchase Agreement dated August 17, 2026, as consideration for the sale of certain assets and rights. On the same date, WTI exercised pre-funded warrants covering 16,570,852 underlying common shares at an exercise price of $0.001 per share, resulting in indirect ownership of 24,854,613 common shares held by WTI. The pre-funded warrants are exercisable immediately, have no expiration date, and are subject to a 19.99% beneficial ownership cap based on the issuer’s outstanding common stock. Each reporting person disclaims beneficial ownership except to the extent of its or his pecuniary interest.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Richard Christian M received a grant of 75,000 restricted stock units (RSUs). Each RSU will convert on a 1-for-1 basis into shares of the company’s common stock, par value $0.001 per share, under the 2025 Equity Incentive Plan for no cash consideration.

The RSUs will vest on June 15, 2027. Subject to award terms and applicable tax withholdings, the company will settle the vested RSUs in common stock no later than the fifteenth day of the third calendar month following the calendar year in which the grant date occurs.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Oei Khing Djien received a grant of 100,000 restricted stock units (RSUs). The award carries a conversion ratio of 1 RSU for 1 share of Cypherpunk Technologies common stock, par value $0.001 per share, and was issued for no cash consideration under the company’s 2025 Equity Incentive Plan.

The RSUs will vest on June 15, 2027. Subject to the RSU terms and applicable tax withholdings, Cypherpunk Technologies will settle the vested RSUs in common stock no later than the fifteenth day of the third calendar month following the calendar year in which the grant date occurs. Following this grant, the filing shows 100,000 derivative units held directly.

Rhea-AI Summary

Cypherpunk Technologies Inc. reported that director Thomas John Dietz received a grant of 100,000 restricted stock units. Each RSU will convert into one share of common stock under the company’s 2025 Equity Incentive Plan and was issued for no cash consideration.

The RSUs vest on June 15, 2027. After vesting, and subject to applicable tax withholdings and award terms, the company will settle the RSUs in common stock by a specified deadline, increasing the director’s potential equity stake if he remains eligible through the vesting date.

Rhea-AI Summary

Cypherpunk Technologies Inc. reported that director Patricia A. Martin received a grant of 75,000 restricted stock units (RSUs). These RSUs were issued for no cash consideration under the company’s 2025 Equity Incentive Plan and will convert into common shares on a 1-for-1 basis.

The RSUs vest on June 15, 2027. Subject to tax withholding and award terms, the company will settle the vested RSUs in common stock no later than the fifteenth day of the third calendar month following the calendar year of the grant date. Following this award, Martin holds 75,000 RSUs directly.

Rhea-AI Summary

LI WILLIAM reported acquisition or exercise transactions in this Form 4 filing.

Cypherpunk Technologies Inc. director William Li reported receiving a grant of restricted stock units as equity compensation. He was awarded 75,000 RSUs, each convertible on a 1-for-1 basis into shares of common stock with $0.001 par value. The RSUs were issued for no cash consideration under the company’s 2025 Equity Incentive Plan. The units are scheduled to vest on June 15, 2027, after which they will be settled in common stock according to the plan’s settlement timetable, bringing his reported derivative holdings tied to this award to 75,000 units.

Rhea-AI Summary

ONSI DOUGLAS E reported acquisition or exercise transactions in this Form 4 filing.

Cypherpunk Technologies Inc. reported that CEO and director Douglas E. Onsi received a grant of 1,000,000 restricted stock units (RSUs), each convertible into one share of common stock. The RSUs were issued for no cash consideration under the company’s 2025 Equity Incentive Plan.

The RSUs begin vesting with 12/36th on June 15, 2027, then 1/36th on the 15th of each following month, as long as he continues serving the company. Vested RSUs will be settled in common stock according to the plan’s stated payout schedule and applicable tax withholdings. Following this award, Onsi holds 1,000,000 RSUs directly.

Rhea-AI Summary

McEvoy William Patrick III reported acquisition or exercise transactions in this Form 4 filing.

Cypherpunk Technologies Inc. reported that Chief Investment Officer and director William Patrick McEvoy III received a grant of 1,000,000 restricted stock units (RSUs). The RSUs were issued for no cash consideration under the company’s 2025 Equity Incentive Plan and settle 1-for-1 into common stock with $0.001 par value.

The RSUs vest over three years, with 12/36 vesting on June 15, 2027, then 1/36 on the 15th day of each following month, subject to his continued service. Following this award, McEvoy holds 1,000,000 RSUs directly, which will be settled in common shares as they vest and are released.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Mashiach Nissim received a grant of 75,000 restricted stock units. Each RSU will convert on a 1-for-1 basis into shares of the company’s common stock, par value $0.001 per share. The RSUs were issued for no cash consideration under the company’s 2025 Equity Incentive Plan and will vest on June 15, 2027, with settlement for common stock required no later than the timetable specified in the award terms.

Rhea-AI Summary

CYPHERPUNK TECHNOLOGIES INC. director Christopher Mirabelli reported an open-market sale of 60,000 shares of Common Stock at an average price of $0.7105 per share on March 26, 2026. According to the footnote, the sale was made to cover estimated taxes related to a previously reported settlement of RSUs on March 13, 2026. After this transaction, Mirabelli directly owns 130,376 shares of the company’s common stock.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Dietz Thomas John exercised previously granted equity awards and increased his direct common share holdings. On March 13, 2026, 104,500 Restricted Stock Units granted on December 23, 2025 under the 2025 Equity Incentive Plan were settled on a 1-for-1 basis into 104,500 shares of common stock for no cash consideration. These RSUs had vested at issuance. Following the settlement, he directly holds 152,500 shares of Cypherpunk Technologies common stock and no remaining RSU position from this grant.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Christopher Mirabelli exercised restricted stock units into common shares as part of his equity compensation. On March 13, 2026, he settled 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 on a 1-for-1 basis into common stock at $0.00 per share. Both RSU grants had vested at issuance. Following these conversions, he directly holds 190,376 shares of common stock and has no remaining derivative positions from these RSUs.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Oei Khing Djien increased his direct holdings through the settlement of previously granted restricted stock units. On March 13, 2026, 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were settled 1-for-1 into common shares for no cash consideration. Both RSU grants had vested at issuance. Following these derivative exercises/conversions, he directly holds 168,750 shares of common stock.

Rhea-AI Summary

Cypherpunk Technologies Inc. director William Li acquired shares through the settlement of previously granted restricted stock units. On March 13, 2026, 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were settled on a 1-for-1 basis into common stock for no cash consideration.

These RSUs vested at issuance on their grant dates and were granted under the company’s 2022 and 2025 equity incentive plans. Following the settlements, Li directly holds 168,750 shares of common stock, and no RSU derivatives from these grants remain outstanding.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Richard Christian M acquired common shares through the settlement of previously granted restricted stock units. On March 13, 2026, 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were each settled 1-for-1 into common stock for no cash consideration. Following these compensation-related conversions, he directly holds 168,750 shares of common stock, with no remaining RSUs reported in this filing and no open-market purchases or sales disclosed.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Mashiach Nissim settled previously granted stock awards into common shares. On March 13, 2026, Nissim exercised and settled 74,700 restricted stock units granted in November 2025 and 94,050 restricted stock units granted in December 2025 on a 1-for-1 basis into the same number of shares of common stock, for no cash consideration. These RSU grants had vested at issuance, and following the settlements Nissim directly owns 168,750 shares of Cypherpunk Technologies common stock. The filing shows no share sales or tax-withholding dispositions associated with these transactions, indicating a net increase in his equity stake.

Rhea-AI Summary

Cypherpunk Technologies Inc. director Patricia A. Martin reported the settlement of previously granted restricted stock units into common shares. On March 13, 2026, 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were exchanged on a 1-for-1 basis for common stock at no cash cost.

These RSUs were granted under the company’s 2022 and 2025 equity incentive plans and vested at issuance on their respective grant dates. Following these settlements and related derivative exercises, Martin directly holds 168,750 shares of Cypherpunk common stock, with no remaining RSUs shown in this filing.

Rhea-AI Summary

Schilsky Richard reported acquisition or exercise transactions in this Form 4 filing.

Cypherpunk Technologies director Richard Schilsky increased his equity stake through RSU settlements, not open-market buying. On March 13, 2026, 74,700 Restricted Stock Units granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were each settled 1-for-1 into common shares for no cash consideration. Both RSU awards had vested at issuance. Following these conversions, Schilsky directly holds 168,750 shares of Cypherpunk Technologies common stock as reported in the filing.

Rhea-AI Summary

Cypherpunk Technologies director Joseph Loscalzo acquired 168,750 common shares through RSU settlements. On March 13, 2026, 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were each settled on a 1-for-1 basis for common stock at no cash exercise price.

Both RSU grants had vested at issuance under the company’s 2022 and 2025 Equity Incentive Plans, and this Form 4 shows a compensation-related derivative exercise rather than any open-market buying or selling. Following these transactions, Loscalzo directly holds 168,750 shares of Cypherpunk common stock with no remaining RSU position reported.

Rhea-AI Summary

Cypherpunk Technologies Inc. director James H. Cavanaugh acquired shares through the settlement of previously granted restricted stock units (RSUs). On March 13, 2026, 74,700 November 2025 RSUs and 94,050 December 2025 RSUs each settled on a 1-for-1 basis into common stock, totaling 168,750 shares.

These RSUs were granted for no cash consideration under the company’s 2022 and 2025 equity incentive plans and had vested at issuance. After these non‑cash, compensation-related exercises/conversions, Cavanaugh directly owned 168,963 shares of Cypherpunk common stock, with no open‑market buying or selling reported in this filing.

Rhea-AI Summary

Cypherpunk Technologies Inc. (CYPH) insiders reported an internal transfer of derivative securities. Winklevoss-affiliated entities filed a Form 4 showing an assignment of warrants for no additional consideration, representing rights to buy 5,616,906 shares of common stock. The warrants are exercisable immediately and expire on 10/08/2035, with an exercise price of $0.5335 per share.

Following the transaction, the reporting persons indirectly beneficially own 57,182,378 warrants through Winklevoss Treasury Investments, LLC. Warrant exercises are limited so that the reporting group’s beneficial ownership does not exceed 19.99% of Cypherpunk’s outstanding common stock after any exercise.

Rhea-AI Summary

Cypherpunk Technologies Inc. (CYPH) director reported significant indirect share sales by affiliated investment entities. On November 17, 2025, HCV VIII Liquidating Trust sold 261,840 shares of common stock at a weighted average price of $3.14 per share, with individual trades ranging from $2.40 to $3.40, as part of its wind up and liquidation. On the same date, HealthCare Ventures IX, L.P. sold 414,479 shares at a weighted average price of $3.14 per share within the same price range, also tied to its liquidation.

Following these transactions, the reporting person is shown as indirectly beneficially owning 416,616 shares through related entities and 2,136 shares through Nine Capital Partners, plus 20,914 shares held directly. The filing notes that beneficial ownership of the fund and trust shares is disclaimed except for the reporter’s proportionate economic interest.

Rhea-AI Summary

Cypherpunk Technologies Inc. director and reporting person filed a Form 4 after a significant share sale tied to a liquidating trust. On November 17, 2025, HCV VIII Liquidating Trust sold 261,840 shares of Cypherpunk common stock as part of the wind up and liquidation of that entity. The weighted average sale price was $3.14 per share, with individual trades reportedly occurring between $2.40 and $3.40 per share. Following the transaction, the reporting person shows 0 shares beneficially owned, held indirectly. The reporting person is a beneficiary of the HCV Liquidating Trust and may have been deemed to beneficially own the shares sold, but expressly disclaims beneficial ownership except for any proportionate pecuniary interest.

Rhea-AI Summary

Cypherpunk Technologies Inc. director and senior officer Douglas E. Onsi filed a Form 4 reporting indirect sales of the company’s common stock on November 17, 2025. A liquidating trust, HCV VIII Liquidating Trust, sold 261,840 shares of common stock at a weighted average price of $3.14 per share, with individual trades ranging from $2.40 to $3.40, as part of its wind up and liquidation. On the same date, HealthCare Ventures IX, L.P. sold 414,479 shares of common stock at a weighted average price of $3.14 per share, also in connection with its wind up and liquidation, with trades in the same $2.40 to $3.40 range.

Following these transactions, Douglas E. Onsi reports 106,146 shares held directly, and indirect beneficial ownership of 416,616 shares and 2,136 shares through affiliated entities. He may be deemed to beneficially own the shares held or sold by these entities but disclaims beneficial ownership except to the extent of his proportionate pecuniary interest.